Read More Pharma Industry News ENB Therapeutics completes Phase 1 trial enrollment for ENB-003 ENB Therapeutics, a biotechnology firm working on therapeutics targeting the endothelin B receptor (ETBR), announced the completion of… byPallavi MadhirajuJuly 19, 2023